124 related articles for article (PubMed ID: 11745784)
21. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
Roberts WJ; Sloan KB
J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
[TBL] [Abstract][Full Text] [Related]
22. Influence of pH on the permeability of p-toluidine and aminopyrine through shed snake skin as a model membrane.
Takahashi K; Sakano H; Rytting JH; Numata N; Kuroda S; Mizuno N
Drug Dev Ind Pharm; 2001 Feb; 27(2):159-64. PubMed ID: 11266227
[TBL] [Abstract][Full Text] [Related]
23. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
Roy SD; Manoukian E
J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
[TBL] [Abstract][Full Text] [Related]
24. Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.
Djordjevic J; Michniak B; Uhrich KE
AAPS PharmSci; 2003 Oct; 5(4):E26. PubMed ID: 15198514
[TBL] [Abstract][Full Text] [Related]
25. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin.
Watkinson RM; Herkenne C; Guy RH; Hadgraft J; Oliveira G; Lane ME
Skin Pharmacol Physiol; 2009; 22(1):15-21. PubMed ID: 19088498
[TBL] [Abstract][Full Text] [Related]
26. Fit of fluxes of sunscreens and other compounds from propylene glycol:water (30:70) through human skin and silicone membrane to the Roberts-Sloan equation: the effect of polar vehicle (or water) solubility.
Sloan KB; Devarajan-Ketha H; Synovec J; Majumdar S
J Cosmet Sci; 2013; 64(3):181-92. PubMed ID: 23752033
[TBL] [Abstract][Full Text] [Related]
27. QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents.
Lien EJ; Gao H
Pharm Res; 1995 Apr; 12(4):583-7. PubMed ID: 7596996
[TBL] [Abstract][Full Text] [Related]
28. An investigation into the influence of counterion on the RS-propranolol and S-propranolol skin permeability.
Cilurzo F; Minghetti P; Alberti E; Gennari CG; Pallavicini M; Valoti E; Montanari L
J Pharm Sci; 2010 Mar; 99(3):1217-24. PubMed ID: 19653283
[TBL] [Abstract][Full Text] [Related]
29. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
George K
Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
[TBL] [Abstract][Full Text] [Related]
30. Prediction of skin permeability of drugs: comparison of human and hairless rat skin.
Morimoto Y; Hatanaka T; Sugibayashi K; Omiya H
J Pharm Pharmacol; 1992 Aug; 44(8):634-9. PubMed ID: 1359085
[TBL] [Abstract][Full Text] [Related]
31. A correlation of flux through a silicone membrane with flux through hairless mouse skin and human skin in vitro.
Wasdo SC; Juntunen J; Devarajan H; Sloan KB
Int J Pharm; 2009 May; 373(1-2):62-7. PubMed ID: 19429289
[TBL] [Abstract][Full Text] [Related]
32. Using a simple equation to predict the microporation-enhanced transdermal drug flux.
Rzhevskiy AS; Telaprolu K; Mohammed YH; Grice JE; Roberts MS; Anissimov YG
Eur J Pharm Biopharm; 2018 Jun; 127():12-18. PubMed ID: 29408519
[TBL] [Abstract][Full Text] [Related]
33. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
34. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
[TBL] [Abstract][Full Text] [Related]
35. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
[TBL] [Abstract][Full Text] [Related]
36. A simple, predictive, structure-based skin permeability model.
Buchwald P; Bodor N
J Pharm Pharmacol; 2001 Aug; 53(8):1087-98. PubMed ID: 11518018
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and transdermal penetration of NSAID glycoside esters.
Swart H; Breytenbach JC; Hadgraft J; du Plessis J
Int J Pharm; 2005 Sep; 301(1-2):71-9. PubMed ID: 16061334
[TBL] [Abstract][Full Text] [Related]
38. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
Bo Nielsen J; Ahm Sørensen J; Nielsen F
J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
[TBL] [Abstract][Full Text] [Related]
39. Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.
Vaddi HK; Hamad MO; Chen J; Banks SL; Crooks PA; Stinchcomb AL
Pharm Res; 2005 May; 22(5):758-65. PubMed ID: 15906171
[TBL] [Abstract][Full Text] [Related]
40. Role of volatile oil pretreatment and skin cholesterol on permeation of ion-paired diclofenac sodium.
Sapra B; Gupta S; Tiwary AK
Indian J Exp Biol; 2000 Sep; 38(9):895-900. PubMed ID: 12561947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
